Cytotoxicity Assays Market

Cytotoxicity Assays Market Overview

The global market for cytotoxicity assays is projected to register a Y-o-Y increase of 8.4% in 2022 to be valued at USD 13,803.92 Million. As of 2021, cytotoxicity assays demand was valued at USD 12,732.37 Million. During the 2022 to 2032 assessment period, the industry is likely to expand at a CAGR of 9.1%.

Report Attribute	Details
Estimated Base Year Value (2021)	USD 12,732.37 Million
Expected Market Value (2022)	USD 13,803.92 Million
Anticipated Forecast Value (2032)	USD 32,978.94 Million
Projected Growth Rate (2022 to 2032)	9.1% CAGR

Cytotoxicity assays are primarily used to determine the effects of hazardous substances or physiological changes in cell type health. Cytotoxicity assays are the most commonly used tool for quantifying cell exposure to a cytotoxic stimulus.

Furthermore, cytotoxicity assays can be used to determine metabolic activity, cell growth inhibition, or cell division. The Cytotoxicity Assay also assists analysts and clinicians in determining the toxicity level of a specific medication or drugs to be used in the market.

Which are Some Prominent Drivers Spearheading Cytotoxicity Assays Market Growth?

One of the most important indicators used in the biological evaluation system is the cytotoxicity assay. Many experimental methods for evaluating cell cytotoxicity are constantly being developed and modernized as modern cell biology advances.

Furthermore, some manufacturers have developed real-time and dynamic methods for quantifying cell morphology, proliferation, and differentiation in cytotoxicity assays.

Following this, other players are attempting to incorporate new real-time cell analysis system technologies into in vitro cytotoxicity tests of medical devices in order to meet the objectives of various tests and also to evaluate the accuracy of in vitro cytotoxicity assays.

What are the Challenges Faced by the Cytotoxicity Assays Industry?

One significant disadvantage is the lack of uniform cytotoxicity test methods. Aside from that, there is no standardized protocol for performing cytotoxicity assays.

Why is North America emerging as an Opportunistic Cytotoxicity Assays Market?

During the forecast period, North America is expected to hold one of the largest shares of the global cytotoxicity assays market. The region's drivers include an increase in haematology and cell proliferation studies, oncology studies, and a variety of other cell-based studies.

How is Asia Pacific Contributing to Growth of the Cytotoxicity Assays Market?

According to Future Market Insights, Asia-Pacific countries, particularly India and China, are expected to grow at a significant rate over the assessment period.

Factors such as a significant increase in the import of these assay kits from leading global manufacturers, as well as the presence of local manufacturers with R&D facilities in the region will drive the growth of the cytotoxicity assays market in this region. 
Japan, with its high R&D investments in medical devices and well-established healthcare infrastructure, will pave the way for the country's cytotoxicity assay market to grow.

Market Competition

Some of the key participants present in the global Cytotoxicity Assays market include F. Hoffman-La Roche AG Thermo Fisher Scientific, Inc, Danaher Corporation, Sakura Finetechnical Co., Ltd and Laboratory Corporation of America Holdings Merck KGaA among others.

Attributed to the presence of such high number of participants, the market is highly competitive.

Scope of Report 

Report Attribute	Details
Growth Rate	CAGR of 9.1% from 2022 to 2032
Base Year for Estimation	2021
Historical Data	2015 to 2020
Forecast Period	2022 to 2032
Quantitative Units	Revenue in USD Billion, Volume in Kilotons and CAGR from 2022 to 2032
Report Coverage	Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis
Segments Covered	Product Type, Application, End User, Region
Regions Covered	North America; Latin America; Europe; South Asia; East Asia; Oceania; Middle East & Africa
Key Countries Profiled	USA, Canada, Brazil, Mexico, Germany, UK, France, Spain, Italy, Nordics, BENELUX, Russia, Australia & New Zealand, China, Japan, South Korea, India, Thailand, Malaysia, Indonesia, GCC, South Africa
Key Companies Profiled	F. Hoffman-La Roche AG; Thermo Fisher Scientific Inc.; Danaher Corporation; Sakura Finetechnical Co., Ltd; Laboratory Corporation of America Holdings; Merck KGaA
Customization	Available Upon Request

Key Segments Profiled in the Cytotoxicity Assays Industry Survey

Product Type:

• Cytotoxicity Assay Based Kits
• Colorimetric Cytotoxicity Based Assays Kits
• Fluorometric Cytotoxicity Based Assays Kits
• Elisa Cytotoxicity Assays Kits
• Crystal Violet Cytotoxicity Assays Kits
• Minimal Inhibitory Concentration Cytotoxicity Assay Kits

Application:

• Cytotoxicity Assays for Nephrotoxicity
• Cytotoxicity Assays for Cardiotoxicity
• Cytotoxicity Assays for Apoptosis
• Cytotoxicity Assays for Cell Proliferation
• Cytotoxicity Assays for Immunohistochemistry
• Cytotoxicity Assays for Reporter Genes
• Cytotoxicity Assays for Transfection Efficacy
• Cytotoxicity Assays for Other Applications

End User Type:

• Cytotoxicity Assays for Hospitals
• Cytotoxicity Assays for Diagnostics Centers
• Cytotoxicity Assays for Academic & Research Laboratories
• Cytotoxicity Assays for Pharma & Biotech Companies
• Cytotoxicity Assays for Other End User Types

Region:

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East & Africa

Table of Content

• 1. Executive Summary
• 2. Industry Introduction, including Taxonomy and Market Definition
• 3. Market Trends and Success Factors, including Macro-economic Factors, Market Dynamics, and Recent Industry Developments
• 4. Global Market Demand Analysis and Forecast, including Historical Analysis and Future Projections
• 5. Pricing Analysis
• 6. Global Market Analysis and Forecast
  • 6.1. Product Type
  • 6.2. Application
  • 6.3. User Type
• 7. Global Market Analysis and Forecast, By Product Type
  • 7.1. Cytotoxicity Assay Based Kits
  • 7.2. Colorimetric Cytotoxicity Based Assays Kits
  • 7.3. Fluorometric Cytotoxicity Based Assays Kits
  • 7.4. Elisa Kits
  • 7.5. Crystal Violet Kits
  • 7.6. Minimal Inhibitory Concentration Cytotoxicity Assay Kits
• 8. Global Market Analysis and Forecast, By Application
  • 8.1. for Nephrotoxicity
  • 8.2. for Cardiotoxicity
  • 8.3. for Apoptosis
  • 8.4. for Cell Proliferation
  • 8.5. for Immunohistochemistry
  • 8.6. for Reporter Genes
  • 8.7. for Transfection Efficacy
  • 8.8. for Other Applications
• 9. Global Market Analysis and Forecast, By User Type
  • 9.1. for Hospitals
  • 9.2. for Diagnostics Centers
  • 9.3. for Academic & Research Laboratories
  • 9.4. for Pharma & Biotech Companies
  • 9.5. for Other End User Types
• 10. Global Market Analysis and Forecast, By Region
  • 10.1. North America
  • 10.2. Latin America
  • 10.3. Europe
  • 10.4. South Asia
  • 10.5. East Asia
  • 10.6. Oceania
  • 10.7. Middle East & Africa
• 11. North America Sales Analysis and Forecast, by Key Segments and Countries
• 12. Latin America Sales Analysis and Forecast, by Key Segments and Countries
• 13. Europe Sales Analysis and Forecast, by Key Segments and Countries
• 14. South Asia Sales Analysis and Forecast, by Key Segments and Countries
• 15. East Asia Sales Analysis and Forecast, by Key Segments and Countries
• 16. Oceania Sales Analysis and Forecast, by Key Segments and Countries
• 17. Middle East & Africa Sales Analysis and Forecast, by Key Segments and Countries
• 18. Sales Forecast by Product Type, Application, and User Type for 30 Countries
• 19. Competition Outlook, including Market Structure Analysis, Company Share Analysis by Key Players, and Competition Dashboard
• 20. Company Profile
  • 20.1. F. Hoffman-La Roche AG
  • 20.2. Thermo Fisher Scientific Inc.
  • 20.3. Danaher Corporation
  • 20.4. Sakura Finetechnical Co., Ltd
  • 20.5. Laboratory Corporation of America Holdings
  • 20.6. Merck KGaA